Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 43.00B | 40.47B | 42.55B | 34.23B | 29.67B | 26.04B |
Gross Profit | 8.12B | 7.44B | 7.68B | 5.73B | 4.36B | 3.21B |
EBITDA | 5.82B | 5.49B | 6.60B | 5.55B | 3.60B | 2.06B |
Net Income | 2.11B | 1.79B | 2.22B | 1.02B | 373.65M | -571.96M |
Balance Sheet | ||||||
Total Assets | 41.88B | 43.72B | 42.68B | 39.28B | 36.84B | 36.90B |
Cash, Cash Equivalents and Short-Term Investments | 9.96B | 9.68B | 10.33B | 8.55B | 6.82B | 7.10B |
Total Debt | 2.92B | 4.44B | 4.08B | 6.71B | 8.20B | 9.25B |
Total Liabilities | 10.26B | 12.66B | 12.53B | 13.96B | 14.12B | 15.74B |
Stockholders Equity | 24.34B | 24.05B | 22.72B | 18.58B | 16.50B | 15.19B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 846.36M | 4.87B | 3.51B | 696.34M | 790.61M |
Operating Cash Flow | 0.00 | 4.42B | 7.42B | 4.98B | 2.37B | 3.06B |
Investing Cash Flow | 0.00 | -3.13B | -2.82B | -1.11B | -1.56B | -1.02B |
Financing Cash Flow | 0.00 | -2.10B | -3.66B | -2.67B | -1.39B | -879.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥9.56B | 4.81 | 5.57% | 1.49% | 78.77% | ||
75 Outperform | ¥9.29B | 3.15 | 2.68% | 2.17% | 66.19% | ||
73 Outperform | ¥8.59B | 6.90 | 3.52% | 8.63% | 9.65% | ||
72 Outperform | ¥10.29B | 5.69 | 3.60% | -4.87% | -19.11% | ||
63 Neutral | ¥15.30B | 242.67 | 4.27% | 2.22% | -90.98% | ||
56 Neutral | HK$23.69B | 3.90 | -1.57% | 6.91% | 0.06% | -64.88% | |
51 Neutral | ¥8.79B | ― | 3.25% | 24.16% | 93.49% |